Experimental Rice U. therapy could repair mutations that cause genetic diseases
A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis.
Rice University bioengineer Gang Bao has combined magnetic nanoparticles with a viral container drawn from a particular species of moth to deliver CRISPR/Cas9 payloads that modify genes in a specific tissue or organ with spatial control.
Because magnetic fields are simple to manipulate and, unlike light, pass easily through tissue, Bao and his colleagues want to use them to control the expression of viral payloads in target tissues by activating the virus that is otherwise inactivated in blood.
The research appears in Nature Biomedical Engineering.
In nature, CRISPR/Cas9 bolsters microbes’ immune systems by recording the DNA of invaders. That gives microbes the ability to recognize and attack returning invaders, but scientists have been racing to adapt CRISPR/Cas9 to repair mutations that cause genetic diseases and to manipulate DNA in laboratory experiments.
CRISPR/Cas9 has the potential to halt hereditary disease – if scientists can get the genome-editing machinery to the right cells inside the body. But roadblocks remain, especially in delivering the gene-editing payloads with high efficiency.
Bao said it will be necessary to edit cells in the body to treat many diseases. “But efficiently delivering genome-editing machinery into target tissue in the body with spatial control remains a major challenge,” Bao said. “Even if you inject the viral vector locally, it can leak to other tissues and organs, and that could be dangerous.”
The delivery vehicle developed by Bao’s group is based on a virus that infects Autographa californica, aka the alfalfa looper, a moth native to North America. The cylindrical baculovirus vector (BV), the payload-carrying part of the virus, is considered large at up to 60 nanometers in diameter and 200-300 nanometers in length. That’s big enough to transport more than 38,000 base pairs of DNA, which is enough to supply multiple gene-editing units to a target cell, Bao said.
He said the inspiration to combine BV and magnetic nanoparticles came from discussions with Rice postdoctoral researcher and co-lead author Haibao Zhu, who learned about the virus during a postdoctoral stint in Singapore but knew nothing about magnetic nanoparticles until he joined the Bao lab. The Rice team had previous experience using iron oxide nanoparticles and an applied magnetic field to open blood vessel walls just enough to let large-molecule drugs pass through.
“We really didn’t know if this would work for gene editing or not, but we thought, ‘worth a shot,’” Bao said.
The researchers use the magnetic nanoparticles to activate BV and deliver gene-editing payloads only where they’re needed. To do this, they take advantage of an immune-system protein called C3 that normally inactivates baculoviruses.
“If we combine BV with magnetic nanoparticles, we can overcome this deactivation by applying the magnetic field,” Bao said. “The beauty is that when we deliver it, gene editing occurs only at the tissue, or the part of the tissue, where we apply the magnetic field.”
Application of the magnetic field allows BV transduction, the payload-delivery process that introduces gene-editing cargo into the target cell. The payload is also DNA, which encodes both a reporter gene and the CRISPR/Cas9 system.
In tests, the BV was loaded with green fluorescent proteins or firefly luciferase. Cells with the protein glowed brightly under a microscope, and experiments showed the magnets were highly effective at targeted delivery of BV cargoes in both cell cultures and lab animals.
Bao noted his and other labs are working on the delivery of CRISPR/Cas9 with adeno-associated viruses (AAV), but he said BV’s capacity for therapeutic cargo is roughly eight times larger. “However, it is necessary to make BV transductioninto target cells more efficient,” he said.
Learn more: Moths and magnets could save lives
The Latest on: Genetic diseases
via Google News
The Latest on: Genetic diseases
- A year in geneticson November 29, 2019 at 8:14 am
We have seen many interesting and field-advancing studies in neurogenomics this year, among which this GWAS has provided novel insights into both ADHD itself and other related disorders. We hope to ...
- Animal Genetics Market Growth boosted by Demand for Animal Protein | Trends, Share, Key Country Analysis by 2023on November 29, 2019 at 6:45 am
On the commercial level, it is utilized for services such as genetic disease testing, DNA typing and genetic trait testing. Get Free Sample Copy @ ...
- Genetic capabilities cut time for potential Texas wheat lines to make field appearanceon November 29, 2019 at 3:32 am
When new pests, diseases or environmental issues are identified in Texas wheat ... Traditional wheat has both parents from wheat lines and has two sets of wheat genetic material or chromosomes. This ...
- In a Wisconsin village, the doctor makes house calls — and sees the rarest diseases on Earthon November 29, 2019 at 2:20 am
He inherited the genetic mutation that causes an illness most people have never heard of: sitosterolemia. Only 100 cases have been described in the medical literature, but DeLine has 13 patients with ...
- Humans and autoimmune diseases continue to evolve togetheron November 28, 2019 at 9:09 am
Mihai G. Netea, chair of experimental internal medicine, examined studies in the fields of virology, genetics, microbiology, and immunology. They focused on people of African or Eurasian descent and ...
- Agios Pharmaceuticals Raised $294 Million to Fight Cancer and Rare Genetic Diseases: What It Means for Investorson November 27, 2019 at 11:39 am
On the pipeline side, Agios' lead candidate, mitapivat, is in late-stage development for a genetic disease called pyruvate kinase deficiency. The company hopes to complete enrollment in the studies ...
- Hibernating mammals arouse hope for genetic solutions to obesity, metabolic diseaseson November 26, 2019 at 8:03 am
Yet when these animals reemerge, they are as fit as ever. Now University of Utah Health scientists say they have detected new genetic clues about this phenomenon that could lead to better ...
- How AI Is Helping Diagnose Rare Genetic Diseaseson November 25, 2019 at 9:14 am
AI has the power to search through millions of genetic variants at high speed and identify likely ... [+] causes of rare diseases, while also comparing what they find with the existing medical ...
- Myriad Genetics' Test Added in Disease Activity Measure Liston November 22, 2019 at 7:52 am
Myriad Genetics, Inc. MYGN announced that its Vectra test was included by the American College of Rheumatology (“ACR”) in its list of recommended disease activity measures for patients with rheumatoid ...
via Bing News